These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 27637307)
1. Use of Direct Oral Anticoagulants in Special Populations. Li A; Lopes RD; Garcia DA Hematol Oncol Clin North Am; 2016 Oct; 30(5):1053-71. PubMed ID: 27637307 [TBL] [Abstract][Full Text] [Related]
2. Direct oral anticoagulants in patients with cancer. Bossaer JB; Covert KL Am J Health Syst Pharm; 2019 Jul; 76(14):1019-1027. PubMed ID: 31361880 [TBL] [Abstract][Full Text] [Related]
3. Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta-analysis. Boonyawat K; Caron F; Li A; Chai-Adisaksopha C; Lim W; Iorio A; Lopes RD; Garcia D; Crowther MA J Thromb Haemost; 2017 Jul; 15(7):1322-1333. PubMed ID: 28407368 [TBL] [Abstract][Full Text] [Related]
4. Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature. Dentali F; Sironi AP; Gianni M; Orlandini F; Guasti L; Grandi AM; Franchini M; Ageno W; Squizzato A Semin Thromb Hemost; 2015 Oct; 41(7):774-87. PubMed ID: 26408921 [TBL] [Abstract][Full Text] [Related]
5. Use of the Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism. Riva N; Ageno W Hematol Oncol Clin North Am; 2016 Oct; 30(5):1035-51. PubMed ID: 27637306 [TBL] [Abstract][Full Text] [Related]
6. Direct oral anticoagulants (DOAC) - Management of emergency situations. Lindhoff-Last E Hamostaseologie; 2017; 37(4):257-266. PubMed ID: 29582928 [TBL] [Abstract][Full Text] [Related]
7. Is it reasonable to use a lower DOAC dose in some patients with VTE? NO. Dentali F; Fantoni C Intern Emerg Med; 2017 Aug; 12(5):565-567. PubMed ID: 28656545 [TBL] [Abstract][Full Text] [Related]
8. Effect of body weight on efficacy and safety of direct oral anticoagulants in the treatment of patients with acute venous thromboembolism: a meta-analysis of randomized controlled trials. Di Minno MN; Lupoli R; Di Minno A; Ambrosino P; Scalera A; Dentali F Ann Med; 2015 Feb; 47(1):61-8. PubMed ID: 25665582 [TBL] [Abstract][Full Text] [Related]
9. Recent evidence for direct oral anticoagulants in chronic kidney disease. Ha JT; Badve SV; Jun M Curr Opin Nephrol Hypertens; 2019 May; 28(3):251-261. PubMed ID: 30789840 [TBL] [Abstract][Full Text] [Related]
10. Oral anticoagulant monitoring: Are we on the right track? Onundarson PT; Flygenring B Int J Lab Hematol; 2019 May; 41 Suppl 1():40-48. PubMed ID: 31069986 [TBL] [Abstract][Full Text] [Related]
11. Direct oral anticoagulants and bleeding risk (in comparison to vitamin K antagonists and heparins), and the treatment of bleeding. Palareti G Semin Hematol; 2014 Apr; 51(2):102-11. PubMed ID: 24861794 [TBL] [Abstract][Full Text] [Related]
12. D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants. Legnani C; Martinelli I; Palareti G; Ciavarella A; Poli D; Ageno W; Testa S; Mastroiacovo D; Ciammaichella M; Bucherini E; Mumoli N; Cosmi B PLoS One; 2019; 14(7):e0219751. PubMed ID: 31310608 [TBL] [Abstract][Full Text] [Related]
13. When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review. Bejjani A; Khairani CD; Assi A; Piazza G; Sadeghipour P; Talasaz AH; Fanikos J; Connors JM; Siegal DM; Barnes GD; Martin KA; Angiolillo DJ; Kleindorfer D; Monreal M; Jimenez D; Middeldorp S; Elkind MSV; Ruff CT; Goldhaber SZ; Krumholz HM; Mehran R; Cushman M; Eikelboom JW; Lip GYH; Weitz JI; Lopes RD; Bikdeli B J Am Coll Cardiol; 2024 Jan; 83(3):444-465. PubMed ID: 38233019 [TBL] [Abstract][Full Text] [Related]
14. Safety of warfarin in "high-risk" populations: A meta-analysis of randomized and controlled trials. Di Minno MN; Ambrosino P; Dentali F Thromb Res; 2017 Feb; 150():1-7. PubMed ID: 27988374 [TBL] [Abstract][Full Text] [Related]
15. Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression. Sagris D; Leventis I; Georgiopoulos G; Korompoki E; Makaritsis K; Vemmos K; Milionis H; Lip GYH; Ntaios G Eur J Intern Med; 2020 Sep; 79():31-36. PubMed ID: 32409203 [TBL] [Abstract][Full Text] [Related]
16. Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation. Plitt A; Ruff CT; Giugliano RP Hematol Oncol Clin North Am; 2016 Oct; 30(5):1019-34. PubMed ID: 27637305 [TBL] [Abstract][Full Text] [Related]
17. Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants. Chan NC; Eikelboom JW; Weitz JI Circ Res; 2016 Apr; 118(9):1409-24. PubMed ID: 27126650 [TBL] [Abstract][Full Text] [Related]
18. Direct Oral Anticoagulants for the Management of Thromboembolic Disorders: The Importance of Adherence and Persistence in Achieving Beneficial Outcomes. Amin A; Marrs JC Clin Appl Thromb Hemost; 2016 Oct; 22(7):605-16. PubMed ID: 26316518 [TBL] [Abstract][Full Text] [Related]
19. Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves. Marcy TR; Truong T; Rai A Consult Pharm; 2015 Nov; 30(11):644-56. PubMed ID: 26629800 [TBL] [Abstract][Full Text] [Related]
20. The use of direct oral anticoagulants in chronic kidney disease. Parker K; Thachil J Br J Haematol; 2018 Oct; 183(2):170-184. PubMed ID: 30183070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]